Literature DB >> 23555644

The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.

Gilles Guerrier1, Eric D'Ortenzio.   

Abstract

BACKGROUND: Leptospirosis is an endemo-epidemic zoonotic disease associated with potentially fatal renal, cardiovascular or pulmonary failure. Recommended treatment includes antibiotics, which may induce a Jarisch-Herxheimer reaction (JHR). Since little information on the importance of this adverse event is available, we performed this review to quantify frequency and impact of JHR in leptospirosis management. METHODOLOGY/PRINCIPAL
FINDINGS: This review systematically summarizes the literature on the JHR in leptospirosis. To approach the broader aspects of the subject, articles considering the treatment of leptospirosis, national leptospirosis guidelines and textbook and technical reports of the World Health Organisation were reviewed. Publications describing JHR in leptospirosis are very limited and consist mainly of single case reports and small case series. A single randomized control trial specifically assessed the JHR occurrence, but it has never been systematically investigated in large trials. Not all guidelines and not all literature on leptospirosis mention this reaction which can be fatal.
CONCLUSIONS/SIGNIFICANCE: Although generally assumed to be a rare event, the true prevalence of JHR in leptospirosis is unknown and the awareness of this event is insufficient. All leptospirosis guidelines and local leptospirosis protocols should stress on systematic monitoring for clinical status early after antibiotic administration. Large well designed studies are required to precise the incidence and the impact of JHR as well as the severity and rates between various antibiotics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23555644      PMCID: PMC3608636          DOI: 10.1371/journal.pone.0059266

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Leptospirosis is a widespread zoonotic disease of worldwide distribution caused by pathogenic Leptospira, a spirochetal organism that is transmitted to humans by exposure to urine of infected mammalian reservoirs such as rodents or wild and domestic animals [1]. The disease has a wide-ranging clinical spectrum from asymptomatic forms to severe presentations. The latter are estimated to occur in 5–15% of all human infections and commonly combine jaundice, renal failure, myocarditis and/or haemorrhage [2] with a significant mortality rate. While a single experimental study demonstrated the relevance of antibiotic administration even in late stages of leptopsirosis [3] the benefit of antibiotic therapy on mortality lacks of clinical evidence [4]. However, the current treatment guidelines still rely on antibiotic administration regardless of stage or severity of the disease [5]. Initiation of chemotherapy in spirochetal diseases may precipitate a febrile inflammatory reaction [6], [7], known as the Jarisch-Herxheimer reaction (JHR), originally described in patients with syphilis receiving mercury treatment [8],[9]. This reaction is characterised by an acute inflammatory response associated with the release of large amounts of cytokines, resulting from clearance of spirochetes from the circulation [6], [7]. Prevalence, clinical manifestations and outcome of JHR have been well studied in syphilis [10], Lyme disease [11], tick-born relapsing fever [12] and louse-born relapsing fever [13]–[15]. However, a clear idea of importance JHR in leptospirosis is lacking. In order to quantify frequency and impact of JHR in leptospirosis, we systematically reviewed the published literature and put it in a broader perspective, identifying data gaps that should be addressed.

Methods

Search Strategy and Selection Criteria

The inclusion criteria were as follows: all publications on leptospirosis treated with antibiotics providing information about the occurrence of early adverse events including JHR were selected. When the original article was not obtainable but the abstract containing the requested information was, the publication was included in the analysis. To avoid multiple counting (duplication) of identical procedures and cases, follow-up publications on identical procedures and cases were traced and excluded. The electronic database PubMed was searched with the keywords “leptospirosis” and “Leptospira”. A second search was performed for “penicillin”, “amoxicillin”, “ampicillin”, “cefepime”, “ceftriaxone” and “antibiotics”. A final search was done with “Jarisch-Herxheimer reaction”. Search results were assessed using different combinations. The search was not limited by study design, language or date of publication. A similar search was conducted with Embase. The Cochrane Library was also searched for leptospirosis publications. World Health Organisation (WHO) websites and international or accessible national guidelines in endemic countries were searched, and the latest editions of five standard textbooks in infectious and tropical diseases were studied [16]–[20]. Titles and abstracts were screened, and potentially relevant case reports, case series and trials were further evaluated. Reports were included if they assessed the occurrence of JHR in leptospirosis. Reference lists of included articles were screened for further relevant publications. Study identification and data extraction were conducted independently and cross-checked for accuracy by both authors.

Data Abstraction and Methodological Assessment

The primary outcome was JHR occurrence or rates measured at time points described by investigators. Secondary outcomes include renal failure rates and mortality. Serovars were also recorded. It was impossible to retrospectively grade the severity of the JHR due to the lack of a standardized definition of the events.

Results

Twenty eight publications met our inclusion criteria, with a total number of 976 leptospirosis cases treated with antibiotics. One publication was a follow-up report on identical case series and therefore excluded from analysis [21]. Abstract or full text was not found for an additional publication which was also excluded [22]. One previous review dedicated to the topic was published in 1991 without systematically assessing the literature [23]. Among the selected studies, 11 patients presenting with concomitant infections were excluded [24].

Studies Characteristics and JHR Occurrence

Eight case reports [25]–[32] and five case series [23], [33]–[36] published between 1955 and 2012 were reviewed and analyzed. All selected patients had a laboratory confirmed leptospirosis without concomitant infection and all were treated with antibiotics. A JHR was reported in 92 patients from 1 to 48 hours after administration of the first dose of antibiotics. The nature of antibiotics regimen given varied considerably: penicillin (n = 81), ampicillin (n = 8), ceftriaxone (n = 1), cefepime (n = 1) and penicillin and ceftriaxone (n = 1). The most common features of described JHR were sudden onset of shivering or rigors (n = 6), with rise in temperature (n = 9), with (n = 8) or without (n = 1) a fall in blood pressure, occurring after administration of the first dose of antibiotics (Table 1). The largest case series accounted for 70 cases, out of 84 case-patients treated with penicillin in Malaya in 1957 [36].
Table 1

Case reports and case series of Jarisch-Heirxheimer reaction after admistration of antibiotics for the treatment of leptospirosis.

ReferencesCountryStudydesignTreatmentadministeredDelaybefore JHRSymptomsOutcome
Lau CL et al.American SamoaCase reportpenicillin1 hourIncrease in feverDischarged
Emerg Infect Dis(n = 1)Rigors
2012Severe Headache
Markham R et al.AustraliaCase reportbenzylpenicillin and2 hoursTachycardiaDischarged
Med J Aust(n = 1)ceftriaxoneTachypnea
2012Hypertension
Severe rigors
Hashimoto T et al.JapanCase reportceftriaxone2 daysPulmonary deteriorationDischarged
J Thorac Imaging(n = 1)
2012
Masuda K et al.JapanCase reportcefepimeUnknownChillsDischarged
Kansenshogaku Zasshi(n = 1)Fever
2010Hypotension
Narita M et al.JapanCase seriesampicillin (n = 6)UnknownRigorsUnknown
Am J Trop Med Hyg(n = 6)Hypotension
2005
Tattevin P et al.FranceCase reportamoxicillin4 hoursHeadacheDischarged
Eur J Clin Microbiol Infect Dis(n = 1)Hypotension
2003Tachycardia
Fever
Nuchal rigidity
Swiader L et al.FranceCase reportpenicillin8 hoursHeadacheUnknown
La Presse Med(n = 1)Photophobia
1995Nuchal rigidity
Vaughan C et al.IrelandCase seriesbenzylpenicillin (n = 2)4 to 5 hoursIncrease in feverDied (n = 1)
Postgrad Med J(n = 3)ampicillin (n = 1)HypotensionDischarged (n = 2)
1994
Emmanouilides CE et al.USACase reportpenicillinFew hoursFeverDischarged
Clin Infect Dis(n = 1)Chills
1991Hypotension
Respiratory distress
Friedland JS et al.UKCase seriesbenzylpenicillin (n = 2)5 hoursFeverDischarged
Rev Infect Dis(n = 2)4 hoursSevere rigor
1991Hypotension
Abdominal pain
Headache
Fever
Profuse vomiting
Winearls CG et al.UKCases seriespenicillin (n = 3)UnknownSharp rise in temperatureDischarged
Q J Med(n = 3)Rigor
1984
Mackay-Dick J et al.MalaysiaCase seriespenicillin (n = 70)UnknownFever (n = 59)Discharged
J Royal Army Medical Corps(n = 70)Aggravation of classicalsymptoms (n = 31)
1957Hypotension (n = 58)
Oligo-anuric (all)
Crooks J et al.ScotlandCase reportpenicillin2 ½ hoursRigorDischarged
Br Med J(n = 1)Fever
1955Weakness
Low blood pressure
Seven randomized control trials (RCT) [21], [24], [37]–[42], six non randomized control trials (NRCT) [43]–[48] were reviewed and analyzed (Table 2). With the exception of two RCTs [41], [42], all studies monitoring the efficacy of antibiotics were not designed to assess adverse events linked to antibiotics including the JHR occurrence. The single study designed to monitor adverse events focusing on leptospirosis-related JHR was performed in 1986 by Watt et al. [42]. In this study, a single Herxheimer-like reaction was observed in a patient receiving saline placebo. The authors concluded that fear of a Herxheimer-like reaction should not dissuade clinicians from administering antibiotics to patients with leptospirosis. However, studied patients received up to four doses of parenteral antibiotic or had completed up to two days of an oral antibiotic regimen before inclusion.
Table 2

Clinical trials for leptospirosis treatment in which adverse events were searched.

ReferencesCountry Yearof studyStudy designTreatmentAny adverse events reportedSystematic assessment of JHRObservationof JHRDelaybefore JHRSymptoms of JHROutcome
Phimda K et al.ThailandRCTdoxycycline (n = 34)RashUnknownNoNANANo death
Antimicrob Agents Chemother2003–2005vsNausea
2007azythromycin (n = 35)Vomiting
Diarrhea
Abdominal pain
Dizziness
Suputtamongkol Y et al.ThailandRCTpenicillin (n = 52)Skin rashUnknownNoNANA4 deaths
Clin Infect Dis2001–2002vs
2004cefotaxime (n = 59)
vs
doxycycline (n = 53)
Panaphut T et al.ThailandRCTceftriaxone (n = 87)NoUnknownNoNANA10 deaths
Clin Infect Dis2000–2001vs
2003penicillin (n = 86)
Costa E et al.BrazilRCTpenicillin (n = 125)NoUnknownNoNANA15 deaths
Rev Inst Med Trop Sao Paulo1997–1999vs
2003placebo (n = 128)
Daher EdF et al.BrazilNRCTpenicillin (n = 16)NoYesNoNANA1 death
Rev Inst Med Trop Sao Paulo1996–1998vs
2000untreated (n = 19)
Marotto PCF et al.BrazilNRCTpenicillin or ampicillin (n = 28)NoUnknownNoNANA1 death
Am J Trop Med Hyg1989–1995(retrospective analysis of children)vs
1997untreated (15)
Watt G et al.PhilippinesRCTpenicillin ((n = 24)NoYesYes (n = 1 in patient receiving placebo)UnknownUnknownNo death
J Infect Dis1985–1986vs
1990placebo (n = 16)
Edwards CN et al.BarbadosRCTpenicillin (n = 38)NoUnknownYes (n = 1 in patient receiving penicillin)3 hoursUnknown4 deaths
Am J Trop Med Hyg1983–1986vs
1986placebo (n = 41)
McClain BL et al.PanamaRCTdoxycycline (n = 14)NoYesNoNANANo death
Ann Intern MedYear not specifiedvs
1984placebo (n = 15)
Russel RW et al.MalayaNRCToxytetracycline (n = 27)PyrexiaNoNoNANAUnknown
LancetYear not specifiedvsSore throat
1958placebo (n = 25)Erythema
Urticaria
Doherty RL et al.AustraliaNRCTpenicillin (n = 71)NoNoNoNANAUnknown
Australas annals of MedicineYear not specifiedvs
1955chloremphenicol (n = 12)
vs
chloremphenicol+penicillin (n = 20)
Fairburn AC et al.MalayaNRCTpenicillin (n = 10)NoNoNoNANANo death
LancetYear not specifiedvs
1956chloramphenicol (n = 14)
vs
placebo (n = 22)
Hall HE et al.Puerto RicoNRCTpenicillin (n = 5)NoNoNoNANA2 deaths
Annals of Internal MedicineYear not specifiedvs
1951chloremphenicol (n = 18)
vs
aureomycin (n = 13)
vs
terramycin (n = 8)
vs
streptomycin (n = 12)
vs
aureomycin+streptomycin (n = 9)
vs
aureomycin+cortison (n = 2)
vs
untreated (n = 12)

RCT: Randomized Control Trial; NRCT: Non Randomized Control Trial.

RCT: Randomized Control Trial; NRCT: Non Randomized Control Trial.

JHR in National and International Guidelines, Textbooks and WHO/ILS Guideline

Among 3 screened national or international guidelines, all described JHR as a potential adverse event, although occurring with penicillin only [5], [49], [50]. Three textbooks out of the five consulted mentioned the possibility of JHR early after penicillin initiation [18]–[20].

JHR Management and Outcome

JHR management was not specified in 82 cases, but reported with no details in five cases (supportive care). In the remaining cases, the management consisted in fluid infusion, vasopressors (n = 1), corticosteroids and inotropic support (n = 1) and transient dialysis (n = 1). Overall, eleven studies mentioned immediate outcome after JHR occurrence. Among them, all cases fully recovered with the exception of one JHR-related death [34].

JHR and Leptospira Serovars

Out of 13 case reports or case series reporting JHR, the pathogen serovar was stated in 18 patients. Nine different types of serovar were involved in JHR-patients, the most prevalent being Icterohaemorrhagiae (n = 6).

Discussion

To the best of our knowledge, this systematic review is the first to formally appraise the measurement of JHR occurrence in leptospirosis treated with antibiotics. Publications describing JHR consist mainly of single case reports or case series. All RCTs included in our review but one were not designed to assess JHR incidence and therefore judged to be of poor methodological quality. Moreover, methods used to monitor JHR were not described in enough detail to reach predefined criteria and to determine whether there was a link between JHR occurrence and organ failure or death. Most reports were targeted at criteria such as duration of fever, clearance of spirochetes and length of stay. The single appropriately designed and detailed RCT had major limitations, including a small number of subjects and a lack of JHR confirmation. However, this work will help to better estimate the potentially detrimental impact of antibiotics in leptospirosis and inform future management guidelines. Since there is little doubt that renal damage can be aggravated by vascular hypotension, particular attention should be paid to monitor blood pressure after initiation of antibiotics in suspected leptospirosis, especially in particular conditions such as pregnant, hypotensive or chronic renal insufficiency presenting patients. Of note, JHR is not reported in studies describing prognostic factors of leptospirosis but clinicians are usually facing complicated management [51], [52]. Interestingly, a higher proportion of JHR occurred in early stage leptospirosis, suggesting a higher probability of the event before the natural clearance of spirochetes. It is postulated that the inflammatory process results from activation of the cytokine cascade during the degeneration of spirochetes. Therefore, the apparent lower proportion of JHR in patients with leptospirosis compared with patients diagnosed with other spirochetal diseases may be explained by a lower bacteraemia. This hypothesis requires further investigation for validation. JHR unobserved or unreported by clinicians is an additional reason for this ostensible reduced frequency. Conversely, a confusion of JHR symptoms with the aggravation of the leptospirosis itself may lead to overestimate the incidence of this event. Interestingly, international guidelines for the management of leptospirosis briefly mention the occurrence of JHR with penicillin, omitting the details of its prevention, management or outcome. Moreover, antibiotics other than penicillin (e.g. ceftriaxone) are not evoked. Similarly, infectious diseases textbooks mentioning the event overlook this reaction with non-penicillin antibiotics. Noteworthy, recommended antibiotics for the management of leptospirosis vary considerably according to settings. For example, most commonly used drugs in the Philippines for mild leptospirosis is doxycyclin while penicillin G is recommended for treating severe cases [50]; amoxicillin and cefotaxim are preferentially used in French Caribbean or in New Caledonia in mild and severe cases, respectively [53]. Some limitations in the current review should be acknowledged. First, potential publication bias is impossible to completely exclude. Moreover, unpublished reports or reports that were not referenced in databases could have been missed despite the comprehensive search. Second, patients presenting with undetected co-infections may have been included in the study. Finally and most importantly, the diagnosis of JHR was not supported by any dosage of biological markers. In addition, the definition of JHR was not uniform, including in the largest case series published by Mackay-Dick [36] which lacks of details such as the onset of reaction. Therefore, although most of the cases presented a genuine JHR, some might have had a clinical aggravation related to the spirochetal disease regardless of the antibiotherapy.

Conclusions

The prevalence of JHR in leptospirosis treated with antibiotics is unknown and the awareness of this adverse event is insufficient. Although this review suggests that antibiotic treatment in patients with leptospirosis may result in less common and less severe JHR than in patients with other spirochetal diseases, all leptospirosis guidelines and local leptospirosis protocols should stress on systematic monitoring for clinical status early after antibiotic administration. We strongly recommend that patients receiving penicillin or other antibiotics for the management of leptospirosis to be monitored early after initiation of treatment to prevent any detrimental effects of a potential JHR. Since it is still controversial whether antimicrobials produce a beneficial effect in mild human leptospirosis, large well designed studies are required integrating a specific monitoring to precise the incidence and the impact of JHR as well as the severity and rates between various antibiotics.
  42 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Meningitis as a possible feature of the Jarisch-Herxheimer reaction in leptospirosis.

Authors:  P Tattevin; S Jauréguiberry; C Michelet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

3.  Clinical pathology of the Jarisch-Herxheimer reaction.

Authors:  A D Bryceson
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

4.  Treatment of leptospirosis with Semicillin.

Authors:  D Münnich; M Lakatos
Journal:  Ther Hung       Date:  1972

5.  Studies of the mechanism of the Jarisch-Herxheimer reaction in louse-borne relapsing fever: evidence for the presence of circulating Borrelia endotoxin.

Authors:  A D Bryceson; K E Cooper; D A Warrell; P L Perine; E H Parry
Journal:  Clin Sci       Date:  1972-09       Impact factor: 6.124

6.  Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure.

Authors:  E F Daher; C B Nogueira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2000 Nov-Dec       Impact factor: 1.846

7.  Doxycycline therapy for leptospirosis.

Authors:  J B McClain; W R Ballou; S M Harrison; D L Steinweg
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

8.  Penicillin at the late stage of leptospirosis: a randomized controlled trial.

Authors:  Everaldo Costa; Antonio Alberto Lopes; Edilson Sacramento; Yara Aragão Costa; Eliana Dias Matos; Marcelo Barreto Lopes; José Carlos Bina
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2003-07-08       Impact factor: 1.846

9.  Pathophysiology and immunology of the Jarisch-Herxheimer-like reaction in louse-borne relapsing fever: comparison of tetracycline and slow-release penicillin.

Authors:  D A Warrell; P L Perine; D W Krause; D H Bing; S J MacDougal
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

10.  An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis.

Authors:  Yupin Suputtamongkol; Kanigar Niwattayakul; Chuanpit Suttinont; Kitti Losuwanaluk; Roongroeng Limpaiboon; Wirongrong Chierakul; Vanaporn Wuthiekanun; Surapee Triengrim; Mongkol Chenchittikul; Nicholas J White
Journal:  Clin Infect Dis       Date:  2004-10-26       Impact factor: 9.079

View more
  25 in total

Review 1.  Leptospirosis: the microscopic danger in paradise.

Authors:  William A Londeree
Journal:  Hawaii J Med Public Health       Date:  2014-11

Review 2.  The Jarisch-Herxheimer Reaction After Antibiotic Treatment of Spirochetal Infections: A Review of Recent Cases and Our Understanding of Pathogenesis.

Authors:  Thomas Butler
Journal:  Am J Trop Med Hyg       Date:  2016-10-24       Impact factor: 2.345

3.  [Treatment of diseases acquired abroad].

Authors:  G-D Burchard
Journal:  Internist (Berl)       Date:  2014-09       Impact factor: 0.743

4.  Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.

Authors:  Gilles Guerrier; Patrick Lefèvre; Chantal Chouvin; Eric D'Ortenzio
Journal:  Am J Trop Med Hyg       Date:  2017-01-23       Impact factor: 2.345

5.  Severity markers in severe leptospirosis: a cohort study.

Authors:  M Mikulski; P Boisier; F Lacassin; M-E Soupé-Gilbert; C Mauron; L Bruyere-Ostells; D Bonte; Y Barguil; A-C Gourinat; M Matsui; F Vernel-Pauillac; C Goarant
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

6.  Risky behaviour: a rare complication of an uncommon disease in a returning traveller.

Authors:  Dominic Pimenta; Jane Democratis
Journal:  BMJ Case Rep       Date:  2013-10-09

7.  Comparative analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2016-06-11       Impact factor: 3.738

8.  Comparative genomic analyses of transport proteins encoded within the genomes of Leptospira species.

Authors:  Bora Buyuktimkin; Milton H Saier
Journal:  Microb Pathog       Date:  2015-08-03       Impact factor: 3.738

9.  Gut microbiota involved in leptospiral infections.

Authors:  Xufeng Xie; Jiuxi Liu; Xi Chen; Shilei Zhang; Ruibo Tang; Xiaoyu Wu; Wenlong Zhang; Yongguo Cao
Journal:  ISME J       Date:  2021-09-29       Impact factor: 10.302

10.  Cluster of Leptospirosis Acquired Through River Surfing in Switzerland.

Authors:  Peter W Schreiber; Leonardo Aceto; Raphael Korach; Nelson Marreros; Marie-Pierre Ryser-Degiorgis; Huldrych F Günthard
Journal:  Open Forum Infect Dis       Date:  2015-07-07       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.